Company Valuation: Boston Scientific Corporation

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 60,534 66,273 84,691 131,642 141,351 66,215 - -
Change - 9.48% 27.79% 55.44% 7.37% -53.16% - -
Enterprise Value (EV) 1 67,674 74,280 92,928 141,974 150,822 72,626 71,710 68,345
Change - 9.76% 25.1% 52.78% 6.23% -51.85% -1.26% -4.69%
P/E 61.6x 103x 54x 71.5x 49.1x 17.3x 18.1x 16.5x
PBR 3.64x 3.77x 4.39x 6.05x 5.84x 2.43x 2.18x 1.98x
PEG - -3x 0x 4.3x 0.9x 0.5x -4.08x 1.6x
Capitalization / Revenue 5.09x 5.23x 5.95x 7.86x 7.04x 3.13x 2.99x 2.82x
EV / Revenue 5.69x 5.86x 6.53x 8.48x 7.51x 3.44x 3.24x 2.91x
EV / EBITDA 16.5x 20.8x 22.6x 29.3x 25.3x 11.2x 10.7x 9.4x
EV / EBIT 22.5x 22.9x 24.9x 31.3x 26.9x 12.4x 11.8x 10.3x
EV / FCF 51.4x 79.2x 51.9x 53.7x 41.2x 19.2x 19.4x 14.9x
FCF Yield 1.94% 1.26% 1.93% 1.86% 2.43% 5.22% 5.16% 6.72%
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 0.69 0.45 1.07 1.25 1.94 2.634 2.518 2.773
Distribution rate - - - - - - - -
Net sales 1 11,888 12,682 14,240 16,747 20,074 21,126 22,136 23,511
EBITDA 1 4,103 3,574 4,106 4,839 5,973 6,495 6,675 7,274
EBIT 1 3,010 3,241 3,738 4,529 5,612 5,845 6,098 6,620
Net income 1 985 642 1,570 1,853 2,898 3,753 3,676 4,189
Net Debt 1 7,140 8,007 8,237 10,332 9,471 6,410 5,495 2,130
Reference price 2 42.48 46.27 57.81 89.32 95.35 45.69 45.69 45.69
Nbr of stocks (in thousands) 1,424,992 1,432,311 1,464,983 1,473,827 1,482,442 1,449,230 - -
Announcement Date 2/2/22 2/1/23 1/31/24 2/5/25 2/4/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
17.34x3.44x11.18x-.--% 66.22B
34.53x5.85x22.47x0.28% 249B
36.99x6.96x21.81x0.63% 162B
51.68x12.65x27.12x-.--% 157B
49.46x12.26x27.02x-.--% 52.3B
20.5x2.46x12.41x2.46% 52.18B
35.31x7.06x22.39x-.--% 51.34B
33.72x6.68x22.73x0.59% 48.79B
79.42x7.56x22.95x-.--% 44.57B
54.47x8.79x31.27x-.--% 40.68B
Average 41.34x 7.37x 22.14x 0.4% 92.42B
Weighted average by Cap. 39.74x 7.52x 22.44x 0.35%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Boston Scientific Corporation

Historical PBR trend

Valuation ratios - PBR - Boston Scientific Corporation

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Boston Scientific Corporation

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Boston Scientific Corporation


Year-on-year evolution of the Yield

Valuation ratios - Yield - Boston Scientific Corporation
  1. Stock Market
  2. Stocks
  3. BSX Stock
  4. Valuation Boston Scientific Corporation